Table 4.
Indication | Number of clinical indications‡ |
Efficacy noted, n |
Nonefficacy noted, n |
Efficacy not documented, n |
---|---|---|---|---|
Control of nociceptive pain | 17 | 9 (52.9) | 3 (17.6) | 5 (29.4) |
Control of neuropathic pain | 20 | 8 (40) | 8 (40) | 4 (20) |
Prevention of withdrawal | 11 | 5 (45.4) | 3 (27.3) | 3 (27.3) |
End-of-life pain management | 3 | 0 | 1 (33.3) | 2 (66.7) |
Total | 51 | 22 (43.1) | 15 (29.4) | 14 (27.5) |
Clinical notes included physicians’ notes, documentation of methadone dosing, and documentation of patient/caregiver’s reports.
Values in parenthesis are represented in percentage.
Ten patients had two concurrent clinical uses.